SCNX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Scienture Holdings Inc (SCNX.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Scienture Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

SCNX News & Events

Events Timeline

No data

News

5.0

2025-12-26Newsfilter

Scienture Launches REZENOPY® with $154 Million Annual Sales Potential

5.0

2025-12-23NASDAQ.COM

Scienture Launches REZENOPY to Address Opioid Overdose Crisis

5.0

2025-12-22Globenewswire

Scienture Launches REZENOPY® with $154 Million Annual Sales Potential

People Also Watch

Frequently Asked Questions

What is Scienture Holdings Inc (SCNX) stock price today?

The current price of SCNX is 0.5601 USD — it has increased 1.27 % in the last trading day.

What is Scienture Holdings Inc (SCNX)'s business?

Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

What is the price predicton of SCNX Stock?

Wall Street analysts forecast SCNX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SCNX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Scienture Holdings Inc (SCNX)'s revenue for the last quarter?

Scienture Holdings Inc revenue for the last quarter amounts to 590.05K USD, increased 809.71 % YoY.

What is Scienture Holdings Inc (SCNX)'s earnings per share (EPS) for the last quarter?

Scienture Holdings Inc. EPS for the last quarter amounts to -0.19 USD, decreased -85.82 % YoY.

What changes have occurred in the market's expectations for Scienture Holdings Inc (SCNX)'s fundamentals?

The market is revising No Change the revenue expectations for SCNX for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -26.68%.

How many employees does Scienture Holdings Inc (SCNX). have?

Scienture Holdings Inc (SCNX) has 14 emplpoyees as of January 10 2026.

What is Scienture Holdings Inc (SCNX) market cap?

Today SCNX has the market capitalization of 22.76M USD.